A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Clinical trial NCT06586957 · RECRUITING
Trial details
- NCT number
- NCT06586957
- Sponsor
- NiKang Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-19
- Primary completion
- 2029-01-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.